South Africa’s Adcock Ingram has seen its sales and operating profit creep up by 1% in its financial first half ended 31 December 2019, calling it a “reasonable set of results in a difficult market.”
Adcock’s generics business has been adversely impacted by stock supply challenges on some key products as well as pricing pressures,...






